)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Xoma
Xoma (XOM) investor relations material
Xoma Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary4 Nov, 2026
Executive summary
Q3 focus remained on advancing FLOW toward industrial use while strengthening financial flexibility; operations remained loss-making.
Q3 operating revenue was SEK 1.615m, including a SEK 1m Nordnet settlement; Q3 net loss was SEK 1.630m.
Financial highlights
Q3 operating revenue rose to SEK 1.615m from SEK 0.325m YoY; 9M revenue was SEK 2.806m vs SEK 0.672m.
Q3 EBITDA was -SEK 1.618m vs -SEK 2.295m; EBIT was -SEK 1.630m vs -SEK 2.329m.
9M EBITDA was -SEK 6.633m vs -SEK 5.763m; EBIT was -SEK 6.873m vs -SEK 5.857m.
9M net loss was SEK 6.875m vs SEK 5.860m; EPS was -SEK 0.06 vs -SEK 0.09.
Revenue included capitalized FLOW development costs and a SEK 1m settlement; 9M operating cash flow after working capital was -SEK 7.590m.
Outlook and guidance
Pilot work with Boliden Rönnskär continues; management plans to provide a clearer timeline.
Algonova Bio's biogenic silica project is underway, with an updated timeline for its listing process to follow.
Management aims to expand domestic and international partnerships while verifying and scaling FLOW technology.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Xoma
- H1 2026 revenue rose, but Q2 sales fell sharply; FLOW tech prioritized amid ongoing losses.XOM
Q2 2026 - FLOW technology reached key milestones, but losses widened despite revenue growth.XOMQ4 2025
- Revenue surged and FLOW pilot project launched, marking a pivotal step in industrial scaling.XOMQ1 2026
- FLOW's technical breakthrough and strong capital base position for growth in water treatment.XOMQ3 2025
- Strategic focus on FLOW, increased losses, and strengthened liquidity after oversubscribed rights issue.XOMQ2 2025
- New partnerships and financing drive Xoma's growth amid rising development costs.XOMQ1 2025
- Direct listing and FLOW launch mark Xoma's shift to growth in algae and water tech.XOMQ4 2024
Next Xoma earnings date
Q4 202618 Feb, 2027
Xoma
Next Xoma earnings date
Q4 202618 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
XOMA Corporation is a biotechnology company focused on licensing and royalty acquisitions related to commercial and late-stage pharmaceutical assets. The company does not develop or market its own products but instead acquires rights to future royalty streams and milestone payments associated with therapeutic candidates developed by other companies. XOMA’s portfolio includes interests in various drug candidates across multiple therapeutic areas. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.